Recent Finacing
Recent Raise
PDC Biotech develops PDC31, a therapeutic candidate targeting preterm labor and primary dysmenorrhea, completing preclinical studies and preparing a Phase I/II clinical trial.
Recent Investors
Funding round
Investors
